This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Source of effectiveness data
The effectiveness evidence was derived from a single study.
Link between effectiveness and cost data
The costing was conducted prospectively on the same sample of patients as that used in the effectiveness analysis.
Study sample
The use of power calculations was not reported. A sample of 160 individuals was referred for investigation of pulmonary TB to the study centre and was enrolled. However, 31 patients (19.4%) did not complete the three induced sputum tests and/or bronchoscopy. The reasons (mainly smear positive on induced sputum testing) for this were reported. Therefore, the final study sample comprised 129 people with a median age of 38 years (age range: 15 -85). The ethnicity distribution was 9.3% European, 8.5% Maori, 11.6% Polynesian, 31% Asian, 20% African and 19.4% other.
Study design
This was a prospective diagnostic study in which the study participants underwent both induced sputum testing and bronchoscopy. The study was conducted at a single centre, the Department of Respiratory Services at the Green Lane Hospital in Auckland. The length of follow-up was unclear, but the patients were likely to have been followed until a diagnosis was made. No patient was lost to the follow-up assessment. The outcome assessment was not blind. Chest radiographs were carried out on each patient to determine the extent, grade and activity of disease. Two respiratory physicians evaluated the results of the radiographic tests without access to other information. In cases of divergent assessments, the final agreement was reached by consensus.
Analysis of effectiveness
The analysis of effectiveness considered all patients who completed the diagnostic procedures. The outcome measures used were: the proportion of patients who tolerated the induced sputum test without difficulty; the diagnostic results of the two techniques; and the results of chest radiography.
Observer variation in the evaluation of radiographs was assessed using the kappa coefficient of agreement. Stepwise logistic regression was used to identify the independent determinates of test results.
Effectiveness results
The proportion of patients who tolerated the induced sputum test without difficulty was 96%.
Of the 129 patients who completed all tests, 27 had active TB, one had active non-tuberculous mycobacteria (NMT), 3 had NMT (probable contaminant), and 98 had no mycobacterial disease.
Of the 27 patients testing positive for TB, 13 were identified by induced sputum test alone, one by bronchoscopy, and 13 by both tests. Therefore, of the 27 positive cases, induced sputum testing identified 26 (96.3%) while bronchoscopy identified 14 (51.9%). Consequently, the induced sputum test was more sensitive than bronchoscopy in diagnosing TB. The difference was statistically significant.
Of the 26 patients who were culture positive on induced sputum testing, 6 were positive on one test, 7 were positive on two tests, and 13 were positive on all three samples. Fifty-four of 129 cases had a recent history of respiratory symptoms or systemic symptoms.
The prevalence of culture positivity on induced sputum was marginally higher in symptomatic patients than in those without symptoms, but the difference was not statistically significant.
Similarly, culture positivity on induced sputum was more frequent in those with respiratory symptoms, (p=0.02), but only marginally more frequent in those with systemic symptoms, (p=0.07).
For chest radiography, inter-observer agreement was good-to-excellent for the assessment of extent of disease, the grading of abnormalities (inactive or potentially active), and the categorisation of disease (unilateral or bilateral).
Of the 129 patients considered in the analysis, 22 had a normal result on chest radiography and were excluded. Thus, 107 patients were left in the sample.
The yield from induced sputum was unrelated to disease extent. However, those in whom radiographic abnormalities suggested possibly active TB had a higher yield from induced sputum (32%) than in patients with inactive appearances (2%). This difference was statistically significant, (p<0.0005).
The logistic regression showed that culture positivity of induced sputum was the only variable associated with radiographic appearances of possibly active disease (odds ratio 23.4; 95% confidence interval: 2.9 -189.3; p=0.003). This was independent of the radiographic extent of disease and the presence of respiratory or systemic symptoms.
Clinical conclusions
The main result of the effectiveness study was that induced sputum testing detected significantly more cases of active TB than bronchoscopy.
Measure of benefits used in the economic analysis
The summary benefit measure used was the number of cases diagnosed with each diagnostic protocol. The benefit was derived from the effectiveness study after knowing the results of bronchoscopy and induced sputum testing.
Direct costs
Discounting was not relevant since the costs were incurred during a short time. The unit costs and the quantities of resources used were not presented separately. The cost analysis included hospital charges, professional fees for physicians and nurses, laboratory charges for bronchoscopy, nursing time, disposable equipment and other consumables, and laboratory charges for three induced sputum tests. The cost/resource boundary was unclear, but it could have been that of the hospital. Resource use was estimated using actual, patient level data, which were derived from the sample of patients involved in the effectiveness study. The costs came from the average of some US hospitals.
The price year was not reported.
